Clinical trial
A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to…
NCT00483964 · Q.Mundewadi Ayurvedic Research & Charitable Trust, Other · Completed
Key facts
| NCT number | NCT00483964 |
|---|---|
| Title | A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia |
| Official title | A Randomized, Controlled ,Clinical Trial of a Herbal Combination of Aqueous Extracts of Bacopa Monnieri and Nardostachys Jatamansi in the Treatment of Schizophrenia, Compared to Standard Anti-Psychotic Drugs |
| Lead sponsor | Q.Mundewadi Ayurvedic Research & Charitable Trust, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Bacopa monnieri, Nardostachys jatamansi, Olanzapine |
| Enrollment | 200 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Jun 8, 2007 |
| Last update posted | Oct 10, 2007 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: